• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

    7/8/24 5:40:41 AM ET
    $AZ
    $BENF
    $CLEU
    $DYNT
    Industrial Machinery/Components
    Industrials
    Finance: Consumer Services
    Finance
    Get the next $AZ alert in real time by email

    Shares of Paramount Global (NASDAQ:PARAA) rose sharply in today's pre-market trading.

    Paramount Global and Skydance Media inked a definitive agreement to create a new entity, "New Paramount," in a $28 billion merger deal.

    Paramount Global shares jumped 7.5% to $22.00 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shapeways Holdings, Inc. (NASDAQ:SHPW) rose 93.7% to $0.4068 in pre-market trading after dipping 22% on Friday.
    • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) shares rose 52.3% to $2.27 in pre-market trading after gaining 8% on Friday.
    • Dynatronics Corporation (NASDAQ:DYNT) shares rose 36.6% to $0.29 in pre-market trading after declining around 8% on Friday.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) gained 27% to $5.17 in pre-market trading after jumping around 50% on Friday.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) shares rose 24.8% to $0.2997 in pre-market trading after jumping over 38% on Friday.
    • Grifols, S.A. (NASDAQ:GRFS) rose 22.9% to $8.65 in pre-market trading. Grifols shares gained around 6% on Friday after the company appointed Rahul Srinivasan as CFO, effective Sept. 16.
    • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shares gained 17.8% to $40.37 in pre-market trading. IDEAYA will present clinical data update for IDE397 Phase 2 monotherapy expansion dose in MTAP-deletion urothelial and lung cancer on July 8, 2024.
    • R1 RCM Inc. (NASDAQ:RCM) shares climbed 13.2% to $12.39 in pre-market trading.
    • NANO Nuclear Energy Inc. (NASDAQ:NNE) shares gained 10.9% to $31.50 in pre-market trading after surging 20% on Friday.

    Losers

    • China Liberal Education Holdings Limited (NASDAQ:CLEU) shares fell 21.6% to $1.71 in pre-market trading after dipping 24% on Friday.
    • Beneficient (NASDAQ:BENF) shares fell 15.1% to $4.11 in pre-market trading. Beneficient said it will release its fourth quarter financial results before the opening bell on Tuesday, July 9.
    • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares declined 14.1% to $0.2408 in pre-market trading after jumping 60% on Friday.
    • Inventiva S.A. (NYSE:IVA) shares fell 13.8% to $2.55 in pre-market trading after the company issued an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 13.3% to $0.2740 in pre-market trading.
    • Adamas One Corp (NASDAQ:JEWL) shares dipped 12.3% to $0.32 in pre-market trading after dipping over 20% on Friday.
    • Vivakor inc (NASDAQ:VIVK) shares fell 11.6% to $2.05 in pre-market trading.
    • A2Z Smart Technologies Corp (NASDAQ:AZ) shares declined 11.5% to $0.38 in pre-market trading after gaining around 11% on Friday.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) shares fell 6.4% to $20.70 in pre-market trading.
    • Stitch Fix, Inc. (NASDAQ:SFIX) fell 5.3% to $3.95 in pre-market trading after gaining over 7% on Friday

    Now Read This: Top 3 Financial Stocks You’ll Regret Missing In Q3

    Get the next $AZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZ
    $BENF
    $CLEU
    $DYNT

    CompanyDatePrice TargetRatingAnalyst
    Inventiva S.A.
    $IVA
    1/28/2026$18.00Overweight
    Barclays
    Inventiva S.A.
    $IVA
    1/12/2026$12.00Outperform
    Leerink Partners
    IDEAYA Biosciences Inc.
    $IDYA
    1/7/2026$50.00Buy
    UBS
    Inventiva S.A.
    $IVA
    1/7/2026$12.00Buy
    UBS
    IDEAYA Biosciences Inc.
    $IDYA
    11/24/2025Buy
    Truist
    Inventiva S.A.
    $IVA
    11/6/2025$13.00Outperform
    Wolfe Research
    IDEAYA Biosciences Inc.
    $IDYA
    9/18/2025$50.00Buy
    Guggenheim
    IDEAYA Biosciences Inc.
    $IDYA
    9/4/2025$40.00Overweight
    Barclays
    More analyst ratings

    $AZ
    $BENF
    $CLEU
    $DYNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Inventiva with a new price target

    Barclays initiated coverage of Inventiva with a rating of Overweight and set a new price target of $18.00

    1/28/26 7:17:30 AM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leerink Partners initiated coverage on Inventiva with a new price target

    Leerink Partners initiated coverage of Inventiva with a rating of Outperform and set a new price target of $12.00

    1/12/26 8:13:43 AM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UBS resumed coverage on IDEAYA Biosciences with a new price target

    UBS resumed coverage of IDEAYA Biosciences with a rating of Buy and set a new price target of $50.00

    1/7/26 9:46:25 AM ET
    $IDYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZ
    $BENF
    $CLEU
    $DYNT
    SEC Filings

    View All

    SEC Form 424B3 filed by Nano Nuclear Energy Inc.

    424B3 - Nano Nuclear Energy Inc. (0001923891) (Filer)

    2/20/26 5:00:09 PM ET
    $NNE
    Electric Utilities: Central
    Utilities

    SEC Form 424B3 filed by Beneficient

    424B3 - Beneficient (0001775734) (Filer)

    2/18/26 6:05:49 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Inventiva S.A.

    SCHEDULE 13G/A - Inventiva S.A. (0001756594) (Subject)

    2/17/26 6:31:01 PM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZ
    $BENF
    $CLEU
    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Albert increased direct ownership by 245% to 358,837 units (SEC Form 5)

    5 - Vivakor, Inc. (0001450704) (Issuer)

    2/17/26 6:43:05 PM ET
    $VIVK
    Environmental Services
    Utilities

    SEC Form 5 filed by Johnson Albert

    5 - Vivakor, Inc. (0001450704) (Issuer)

    2/17/26 6:42:40 PM ET
    $VIVK
    Environmental Services
    Utilities

    SEC Form 3 filed by new insider Johnson Albert

    3 - Vivakor, Inc. (0001450704) (Issuer)

    2/17/26 6:42:02 PM ET
    $VIVK
    Environmental Services
    Utilities

    $AZ
    $BENF
    $CLEU
    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A2Z Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

    TORONTO, Feb. 23, 2026 /CNW/ - A2Z Cust2Mate Solutions Corp. (NASDAQ:AZ) (the "Company" or "A2Z"), a global leader in innovative technology solutions, today announced its preliminary, unaudited revenues for the fourth quarter and full-year ended December 31, 2025, as presented below. The preliminary unaudited revenues described in this press release are based on the most current information available to management and are subject to change until the audit of the company's 2025 financial results is completed and the company reports its full financial results for the fourth quarter and full-year 2025, which is anticipated to occur in late March 2026. Company has started to recognize meaningful

    2/23/26 7:00:00 AM ET
    $AZ
    Industrial Machinery/Components
    Industrials

    IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer

    SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D and Site Head for the Bay Area. 

    2/23/26 6:00:00 AM ET
    $IDYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NANO Nuclear Expands its Nuclear Policy Leadership Expertise with the Appointment of U.S. Government Veteran Sarah Lennon as its International Nuclear Policy Advisor

    New York, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced the appointment of Sarah Lennon as its International Nuclear Policy Advisor. Sarah is a seasoned national security and nuclear energy policy leader with three decades of distinguished service across the U.S. Government, bringing deep expertise in nuclear security, nonproliferation, international cooperation, and strategic planning. "It is a pleasure to join the NANO Nuclear team," said Sarah Lennon, International Nuclear Policy A

    2/20/26 8:30:00 AM ET
    $NNE
    Electric Utilities: Central
    Utilities

    $AZ
    $BENF
    $CLEU
    $DYNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cangany Peter T Jr bought $23,750 worth of shares (25,000 units at $0.95) (SEC Form 4)

    4 - Beneficient (0001775734) (Issuer)

    11/25/24 4:29:26 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Director Cangany Peter T Jr bought $69,500 worth of shares (75,000 units at $0.93) (SEC Form 4)

    4 - Beneficient (0001775734) (Issuer)

    11/20/24 6:03:20 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Chief Technology Officer Rutledge Maria S. bought $999 worth of shares (900 units at $1.11), increasing direct ownership by 55% to 2,540 units (SEC Form 4)

    4 - Beneficient (0001775734) (Issuer)

    9/27/24 6:03:41 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    $AZ
    $BENF
    $CLEU
    $DYNT
    Leadership Updates

    Live Leadership Updates

    View All

    IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer

    SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the appointment of Dr. Theodora (Theo) Ross into the newly created role of Chief Development Officer. In this role, Dr. Ross will be responsible for leading early clinical development for IDEAYA's emerging oncology pipeline and play a crucial role in guiding the company's long-term R&D strategy. Dr. Ross joins IDEAYA from AbbVie, where she served as Vice President, Head of Early Oncology R&D and Site Head for the Bay Area. 

    2/23/26 6:00:00 AM ET
    $IDYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NANO Nuclear Expands its Nuclear Policy Leadership Expertise with the Appointment of U.S. Government Veteran Sarah Lennon as its International Nuclear Policy Advisor

    New York, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced the appointment of Sarah Lennon as its International Nuclear Policy Advisor. Sarah is a seasoned national security and nuclear energy policy leader with three decades of distinguished service across the U.S. Government, bringing deep expertise in nuclear security, nonproliferation, international cooperation, and strategic planning. "It is a pleasure to join the NANO Nuclear team," said Sarah Lennon, International Nuclear Policy A

    2/20/26 8:30:00 AM ET
    $NNE
    Electric Utilities: Central
    Utilities

    NANO Nuclear Strengthens Nuclear Regulatory Licensing Team with Appointment of Michael Montecalvo as its Licensing Director

    Michael Montecalvo joins NANO Nuclear following Senior Licensing Manager role at other advanced reactor developers and previous experience with the U.S. Nuclear Regulatory Commission (NRC) New York, N.Y., Jan. 28, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced that it has appointed former NRC professional, Michael Montecalvo as its Licensing Director. Mr. Montecalvo's appointment strengthens NANO Nuclear's already experienced regulatory and licensing capabilities as NANO Nuclear continues to develop

    1/28/26 8:30:00 AM ET
    $NNE
    Electric Utilities: Central
    Utilities

    $AZ
    $BENF
    $CLEU
    $DYNT
    Financials

    Live finance-specific insights

    View All

    Stitch Fix Announces Date for Second Quarter 2026 Financial Results and Conference Call

    Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2026 ended January 31, 2026 after market close on Wednesday, March 11, 2026. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone particip

    2/18/26 4:05:00 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    Beneficient Reports Third Quarter Fiscal 2026 Results

    DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 third quarter, which ended December 31, 2025. Highlights of the quarter include: Resolved GWG Holdings, Inc. litigation and regained Nasdaq complianceGenerated $50 million in gross proceeds from asset salesFully paid off HH-BDH Credit Agreement principal balance (excluding $1.7 million for deferred interest and fees)Strengthened balance sheet and collateral base Commenting on the

    2/17/26 5:00:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    ZIM to be Acquired by Hapag-Lloyd for $35.00 per Share in Cash at Aggregate Cash Consideration of Approximately $4.2 Billion; New Israeli Company, "New ZIM", to Acquire Portion of ZIM's Business

    Represents 58% Premium to ZIM's Prior-Day Closing Stock Price and 126% Premium to ZIM's Unaffected Stock PriceCombined Company Will Increase its Service Offerings to Customers Through an Expanded Global Network on Key Transpacific, Intra Asia, Atlantic, Latin America and East Mediterranean TradesFIMI Opportunity Funds Will Form "New ZIM" with 16 Vessels Securely Serving Main Global Trade Routes into Israel"New ZIM" Will Receive Commercial Support from Hapag-Lloyd and Will Have Access to Gemini NetworkTransaction Expected to Close by Late 2026HAIFA, Israel, Feb. 16, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company") today announced that it has enter

    2/16/26 9:21:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $AZ
    $BENF
    $CLEU
    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Paramount Global

    SC 13D/A - Paramount Global (0000813828) (Subject)

    12/12/24 4:14:51 PM ET
    $PARAA
    Broadcasting
    Industrials

    Amendment: SEC Form SC 13D/A filed by Maxeon Solar Technologies Ltd.

    SC 13D/A - Maxeon Solar Technologies, Ltd. (0001796898) (Subject)

    11/26/24 8:54:35 PM ET
    $MAXN
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    11/22/24 4:06:56 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary